HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.

Abstract
The molecular mechanism of factor Xa (FXa) inhibition by Alboserpin, the major salivary gland anticoagulant from the mosquito and yellow fever vector Aedes albopictus, has been characterized. cDNA of Alboserpin predicts a 45-kDa protein that belongs to the serpin family of protease inhibitors. Recombinant Alboserpin displays stoichiometric, competitive, reversible and tight binding to FXa (picomolar range). Binding is highly specific and is not detectable for FX, catalytic site-blocked FXa, thrombin, and 12 other enzymes. Alboserpin displays high affinity binding to heparin (K(D) ~ 20 nM), but no change in FXa inhibition was observed in the presence of the cofactor, implying that bridging mechanisms did not take place. Notably, Alboserpin was also found to interact with phosphatidylcholine and phosphatidylethanolamine but not with phosphatidylserine. Further, annexin V (in the absence of Ca(2+)) or heparin outcompetes Alboserpin for binding to phospholipid vesicles, suggesting a common binding site. Consistent with its activity, Alboserpin blocks prothrombinase activity and increases both prothrombin time and activated partial thromboplastin time in vitro or ex vivo. Furthermore, Alboserpin prevents thrombus formation provoked by ferric chloride injury of the carotid artery and increases bleeding in a dose-dependent manner. Alboserpin emerges as an atypical serpin that targets FXa and displays unique phospholipid specificity. It conceivably uses heparin and phosphatidylcholine/phosphatidylethanolamine as anchors to increase protein localization and effective concentration at sites of injury, cell activation, or inflammation.
AuthorsEric Calvo, Daniella M Mizurini, Anderson Sá-Nunes, José M C Ribeiro, John F Andersen, Ben J Mans, Robson Q Monteiro, Michail Kotsyfakis, Ivo M B Francischetti
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 286 Issue 32 Pg. 27998-8010 (Aug 12 2011) ISSN: 1083-351X [Electronic] United States
PMID21673107 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Insect Proteins
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Phosphatidylserines
  • Serpins
  • phosphatidylethanolamine
  • Heparin
  • Factor Xa
Topics
  • Aedes (chemistry, genetics, metabolism, virology)
  • Animals
  • Blood Coagulation
  • Factor Xa (chemistry, genetics, metabolism)
  • Factor Xa Inhibitors
  • Fibrinolytic Agents (chemistry, metabolism)
  • Heparin (chemistry, genetics, metabolism)
  • Humans
  • Insect Proteins (chemistry, genetics, metabolism)
  • Insect Vectors (chemistry, metabolism, virology)
  • Mice
  • Phosphatidylcholines (chemistry, genetics, metabolism)
  • Phosphatidylethanolamines (chemistry, genetics, metabolism)
  • Phosphatidylserines (chemistry, genetics, metabolism)
  • Protein Binding
  • Serpins (chemistry, genetics, metabolism)
  • Yellow Fever

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: